FDA reviews MDMA therapy for PTSD, citing health risks and study flaws
Research like the current research into MDMA therapy has blocked support from various groups and lawmakers in both parties for treating post-traumatic stress disorder, a condition that affects millions of Americans, particularly military veterans who are at enormous risk of suicide . No new treatments for PTSD have been approved for more than 20 years. “What's happening is really a paradigm shift for psychiatry,” said David Olson, director of the Institute for Psychedelia and Neurotherapy at UC Davis. “MDMA represents an important step for the industry because there is a real lack of effective treatments and people need help now.”…